CAre of Patients With PArenteral Nutrition At Home (CAPANAH)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01545063|
Recruitment Status : Completed
First Posted : March 6, 2012
Last Update Posted : July 19, 2017
This research aims to give an overview of a number of aspects related to the quality of care for adult patients on home parenteral nutrition.
Concretely this study follows up different aspects on different moments in the care of the patient pathways:
- process indicators concerning indication, parenteral nutrition, training, team access roads and the succession of complications
- Outcome indicators
- the health-related quality of life
- discrepancies in medication use
- the role of the different health care providers
|Condition or disease|
|Crohn's Disease Peritoneal Carcinomatosis With Intestinal Occlusion Radiation Enteritis Chronic Diarrhea Intestinal Lymphomas|
Adult patients on HPN will be contacted by phone at three different time moments after their discharge to ask them about indicators, quality of life and discrepancies in medication use. After the follow-up, medical dossiers will be consulted to know which indicators are followed in practice.
The role of the different health care providers will be investigated by face-to-face interviews with different healthcare professionals.
|Study Type :||Observational|
|Actual Enrollment :||39 participants|
|Official Title:||Prospective Non-interventional Non-controlled Multicenter Observational Study to Evaluate the Quality of Care for Adult Patients on Home Parenteral Nutrition (HPN)|
|Actual Study Start Date :||May 2012|
|Actual Primary Completion Date :||April 2013|
|Actual Study Completion Date :||April 2013|
- Quality of life [ Time Frame: 2 years ]Quality of life will be investigated with the HPN-QoL(r) or FACIT-G (r).
- Number of catheter related infections [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01545063
|UZA Antwerpen Edegem|
|Imelda Ziekenhuizen Bonheide|
|University Centrum Brussel|
|AZ Sint Blasius Dendermonde|
|Ziekenhuis Oost Limburg|
|AZ Sint Lucas en Volkskliniek|
|Hasselt Jessa Ziekenhuizen|
|Leuven, Belgium, 3000|
|Heilig Hart vzw|
|Roeselare Menen, Belgium|